Literature DB >> 10189350

Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype?

E N Olson1, J D Molkentin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10189350     DOI： 10.1161/01.res.84.6.623

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  25 in total

Review 1.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.

Authors:  N H Purcell; G Tang; C Yu; F Mercurio; J A DiDonato; A Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

3.  O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.

Authors:  Heberty T Facundo; Robert E Brainard; Lewis J Watson; Gladys A Ngoh; Tariq Hamid; Sumanth D Prabhu; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733

4.  Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Authors:  T Taigen; L J De Windt; H W Lim; J D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

5.  miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.

Authors:  Kun Wang; Bo Long; Jing Zhou; Pei-Feng Li
Journal:  J Biol Chem       Date:  2010-02-21       Impact factor: 5.157

6.  Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice.

Authors:  Nicole Stupka; David R Plant; Jonathan D Schertzer; Tennent M Emerson; Rhonda Bassel-Duby; Eric N Olson; Gordon S Lynch
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

Review 7.  Proteotoxicity and cardiac dysfunction.

Authors:  Patrick M McLendon; Jeffrey Robbins
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

8.  Calcitonin gene-related peptide is not essential for the development of pressure overload-induced hypertrophy in vivo.

Authors:  M E Young; K A Okerberg; C R Wilson; D A Deferrari; J Ying; P Guthrie; P Razeghi; F J Clubb; H Taegtmeyer
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

9.  Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.

Authors:  L J De Windt; H W Lim; O F Bueno; Q Liang; U Delling; J C Braz; B J Glascock; T F Kimball; F del Monte; R J Hajjar; J D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

10.  Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.

Authors:  H Diedrichs; C Mei; K F Frank; B Boelck; R H G Schwinger
Journal:  J Mol Med (Berl)       Date:  2004-08-20       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.